Provided by Tiger Fintech (Singapore) Pte. Ltd.

Celldex Therapeutics

21.35
+1.829.32%
Post-market: 21.350.0060+0.03%18:01 EDT
Volume:852.59K
Turnover:17.77M
Market Cap:1.42B
PE:-7.91
High:21.43
Open:19.87
Low:19.87
Close:19.53
Loading ...

Celldex Therapeutics Files Initial Statement of Beneficial Ownership for Director Denice Torres

Reuters
·
06 Jun

Celldex Therapeutics Announces Election of Denice Torres to Its Board of Directors

THOMSON REUTERS
·
06 Jun

Celldex Therapeutics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
09 May

UBS Adjusts Price Target on Celldex Therapeutics to $38 From $44, Maintains Buy Rating

MT Newswires Live
·
09 May

Celldex price target lowered to $38 from $44 at UBS

TIPRANKS
·
09 May

Stock Track | Celldex Therapeutics Plummets 6.76% as Morgan Stanley Cuts Target Price

Stock Track
·
09 May

Celldex Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
09 May

Celldex Therapeutics Inc : Morgan Stanley Cuts Target Price to $43 From $46

THOMSON REUTERS
·
09 May

Celldex Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Celldex Therapeutics Q1 EPS $(0.81) Misses $(0.74) Estimate, Sales $695.00K Miss $1.05M Estimate

Benzinga
·
09 May

Celldex Therapeutics Q1 Revenue USD 695 Thousand

THOMSON REUTERS
·
09 May

Celldex Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview

Reuters
·
06 May

Celldex Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow Jones
·
06 May

Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease

GlobeNewswire
·
06 May

Canada's Northern Graphite plans to put Quebec mine on care and maintenance

Reuters
·
01 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
01 May

Celldex Therapeutics Initiated at Buy by Canaccord Genuity

Dow Jones
·
28 Apr

BUZZ-U.S. STOCKS ON THE MOVE-KKR, Micron Technology, Eli Lilly

Reuters
·
20 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Five Below, QXO, PDD Holdings

Reuters
·
20 Mar

BUZZ-MS starts coverage on Celldex, bullish view on company's skin disease treatment

Reuters
·
20 Mar